Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline <em>BRCA</em> mutation carriers and wild-type <em>BRCA</em> pancreatic ductal adenocarcinoma

January 18, 2018

Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline <em>BRCA</em> mutation carriers and wild-type <em>BRCA</em> pancreatic ductal adenocarcinoma

Published on 01/17/2018

previous post: Do any weight loss pills really work?
next post: Relation of bleeding events to mortality in patients with ST-segment elevation myocardial infarction treated by percutaneous coronary intervention (a DANAMI-3 Substudy)